Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Klara Havlova"'
Autor:
Marcela Cechova, Matus Chocholaty, Marek Babjuk, Tomas Zima, Klara Havlova, Marketa Koldova, Marek Schmidt, Marta Kalousova
Publikováno v:
Biomedical Papers, Vol 165, Iss 4, Pp 375-379 (2021)
Background and Aim: Placental Growth Factor (PlGF) plays a crucial role in angiogenesis and was identified as a potential prognostic biomarker in various types of cancer. Therefore, we evaluated the diagnostic accuracy and prognostic value of PlGF se
Externí odkaz:
https://doaj.org/article/2f0e69117d8a4b63859c4fc8180da4e3
Autor:
Martin Snajdauf, Klara Havlova, Jiri Vachtenheim, Andrej Ozaniak, Robert Lischke, Jirina Bartunkova, Daniel Smrz, Zuzana Strizova
Publikováno v:
Frontiers in Molecular Biosciences, Vol 8 (2021)
TRAIL (tumor-necrosis factor related apoptosis-inducing ligand, CD253) and its death receptors TRAIL-R1 and TRAIL-R2 selectively trigger the apoptotic cell death in tumor cells. For that reason, TRAIL has been extensively studied as a target of cance
Externí odkaz:
https://doaj.org/article/fbf946f47c644b1e884e13dae81ac836
Autor:
Jirina Bartunkova, S. Vesely, Dmitry Stakheev, Daniel Smrz, Pavla Taborska, Klara Havlova, Zuzana Strizova, Simona Partlova
Publikováno v:
Urologic Oncology: Seminars and Original Investigations. 37:503-509
Objectives Renal cell carcinoma (RCC) is the most lethal urologic malignancy with increasing incidence worldwide. The conventional treatment strategies for advanced or recurrent RCC are not efficient and show considerable toxicities. Adoptive cell tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::daf77da6aec7e3dab43801285fcd958b
https://doi.org/10.1016/j.urolonc.2019.03.014
https://doi.org/10.1016/j.urolonc.2019.03.014
Autor:
Andrej Ozaniak, Jirina Bartunkova, Klara Havlova, Martin Snajdauf, Daniel Smrz, Jiri Vachtenheim, Zuzana Strizova, Robert Lischke
Publikováno v:
Frontiers in Molecular Biosciences, Vol 8 (2021)
Frontiers in Molecular Biosciences
Frontiers in Molecular Biosciences
TRAIL (tumor-necrosis factor related apoptosis-inducing ligand, CD253) and its death receptors TRAIL-R1 and TRAIL-R2 selectively trigger the apoptotic cell death in tumor cells. For that reason, TRAIL has been extensively studied as a target of cance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62a68f975bdcb31f8ba710f378228f00
https://www.frontiersin.org/articles/10.3389/fmolb.2021.628332/full
https://www.frontiersin.org/articles/10.3389/fmolb.2021.628332/full
Publikováno v:
Folia parasitologica. 67
Babesiosis is a tick-borne disease that may exhibit a broad range of clinical manifestations. According to the Food and Drug Administration (FDA), Babesia species belong to the most common transfusion-transmitted pathogens (FDA, May 2019), but the aw
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c6deb1ef8c114bf30bb381664000560
https://pubmed.ncbi.nlm.nih.gov/33173020
https://pubmed.ncbi.nlm.nih.gov/33173020
Autor:
Tomáš Zima, Klara Havlova, M. Chocholatý, Marie Jáchymová, Anna Křepelová, Marta Kalousová, Marko Babjuk, Marek Schmidt
Publikováno v:
Tumor Biology. 36:2121-2126
The receptor for advanced glycation end products (RAGE) and its ligands are involved in the pathogenesis of cancer. Glyoxalase I (GLO1) is an enzyme which detoxifies advanced glycation end product (AGE) precursors. The aim of the study was to find ou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c99542c41f24d3573e913cacfe9e8143
https://doi.org/10.1007/s13277-014-2821-0
https://doi.org/10.1007/s13277-014-2821-0